Fundraising Fox

Deborah Harland

Investor

Advisor at SR One Capital Management Β· Chair, LifeArc Ventures Investment Committee at LifeArc Ventures Β· Independent Advisor of the Investment Committee at British Business Investments

Hemel Hempstead, England, United Kingdom

Find your path to Deborah

602 people in our graph share verified history with Deborah β€” schools, employers, funds. One of them is your warm intro.

Freya Svedberg-KeatingunlockedDeborah: together at SR One Capital Management (2023)
Γ—2Deborah: together at SmithKline Beecham
Γ—3Deborah: together at University of London
Γ—4Deborah: together at University of Bath

About

Appointed Chair of the Ventures Investment Committee in October 2022, with 20 years at SR One as partner and venture partner. Serves as an independent investment committee member at British Patient Capital and has held numerous non-executive board roles across biotech.

Experience

  1. British Business BankIndependent Advisor of the Investment Committeecurrent2026 β€” present
  2. British Business BankIndependent Investment Committee Member, British Patient Capital2023 β€” 2026
  3. SR One Capital ManagementAdvisorcurrent2023 β€” present
  4. SR One Capital ManagementVenture Partner2020 β€” 2022
  5. SR One Capital ManagementPartner2009 β€” 2020
  6. SR One Capital ManagementGeneral Partner2005 β€” 2009
  7. LifeArcChair, Ventures Investment Committeecurrent2022 β€” present
  8. VHsquared LimitedNon Executive Directorcurrent2013 β€” presentCambridge, United Kingdom
  9. Cancer Research HorizonsNon Executive Director2015 β€” 2026London, United Kingdom
  10. Asceneuron SANon Executive Director2015 β€” 2022Lausanne Area, Switzerland
  11. MISSION TherapeuticsNon Executive Director2011 β€” 2022
  12. MiroBio LtdNon Executive Director2019 β€” 2022Oxford, England, United Kingdom
  13. f-star GmbHNon Executive Director2011 β€” 2020
  14. SR One (GlaxoSmithKline Venture Capital Group)Partner2009 β€” 2020
  15. Bicycle Therapeutics LimitedNon Executive Director2009 β€” 2019
  16. Protaffin Biotechnologie AGNon Executive Director2009 β€” 2014
  17. Syntaxin LtdNon Executive Director2007 β€” 2013
  18. GSKDirector, Scientific Licensing, Worldwide Business Development2001 β€” 2005
  19. SmithKline BeechamDirector Medical Affairs and Business Development Liaison1998 β€” 2001Essex, England, United Kingdom
  20. SmithKline BeechamClinical Scientist/Assistant Director/Associate Director Clinical Development1991 β€” 1998Essex, England, United Kingdom
  21. Merrell DowClinical Research Associate1989 β€” 1991Strasbourg, Grand Est, France
  22. University of Nottingham Medical SchoolBritish Heart Foundation/Wellcome Trust Postdoctoral Research Fellow1985 β€” 1988Nottingham, England, United Kingdom

Skills & more

Biotechnology26Lifesciences14Venture Capital8Technology Transfer24Due Diligence3Drug Discovery18Commercialization28Start-ups4Mergers1Corporate Development3R&D3Entrepreneurship2
+7 moreBusiness StrategyClinical DevelopmentM&A experienceDrug DevelopmentLife SciencesStrategyPharmaceutical Industry

Languages French

From Deborah's professional profile.

Colleagues at SR One Capital Management

Frequently asked questions

Who is Deborah Harland?
Appointed Chair of the Ventures Investment Committee in October 2022, with 20 years at SR One as partner and venture partner. Serves as an independent investment committee member at British Patient Capital and has held numerous non-executive board roles across biotech.
Where does Deborah Harland work?
Deborah Harland is Advisor at SR One Capital Management.
Where did Deborah Harland go to school?
Deborah Harland studied at Henley Business School (MBA, Management and Business); University of London (PhD, Pharmacology); University of Bath (B.Sc (Hons), Pharmacology).

Same school

Shared employers